Trial Profile
A Multicenter, Randomized, Masked, Placebo-Controlled Trial to Assess the Safety and Efficacy of Lucinactant in Acute Hypoxemic Respiratory Failure in Children Up to Two Years of Age
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2016
Price :
$35
*
At a glance
- Drugs Sinapultide (Primary)
- Indications Respiratory insufficiency
- Focus Therapeutic Use
- Sponsors Discovery Laboratories
- 18 May 2014 New trial record
- 24 Jun 2010